A Study of Alectinib, Entrectinib, or Vemurafenib Plus Cobimetinib in Participants With Stages I-III Non-Small Cell Lung Cancer With ALK, ROS1, NTRK, or BRAF v600E Molecular Alterations

Case Medical Research ◽

10.31525/ct1-nct04302025 ◽

2020 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Molecular Alterations

Download Full-text

Association of programmed cell death 1 ligand (PD-L1) expression with molecular alterations in non-small cell lung cancer (NSCLC) patients (pts): Results from the European Thoracic Oncology Platform (ETOP) Lungscape cohort

Annals of Oncology ◽

10.1093/annonc/mdx390.002 ◽

2017 ◽

Vol 28 ◽

pp. v573-v574

Author(s):

K.M. Kerr ◽

E. Thunnissen ◽

U. Dafni ◽

A. Soltermann ◽

S. Finn ◽

...

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Molecular Alterations ◽

Programmed Cell Death 1 ◽

Download Full-text

Phase 2 trial (BRF113928) of dabrafenib (D) plus trametinib (T) in patients (pts) with previously untreated BRAF V600E–mutant metastatic non-small cell lung cancer (NSCLC)

Annals of Oncology ◽

10.1093/annonc/mdx440.054 ◽

2017 ◽

Vol 28 ◽

pp. v637 ◽

Author(s):

D. Planchard ◽

E.F. Smit ◽

H.J.M. Groen ◽

J. Mazieres ◽

B. Besse ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase 2 ◽

Small Cell Lung ◽

Download Full-text

Adding to the targeted therapy toolbox: BRAF and MEK inhibition in the treatment of BRAF V600E metastatic non-small cell lung cancer

Translational Cancer Research ◽

10.21037/tcr.2016.11.50 ◽

2016 ◽

Vol 5 (S6) ◽

pp. S1233-S1240

Author(s):

Nathaniel J. Myall ◽

Heather A Wakelee

Keyword(s):

Lung Cancer ◽

Targeted Therapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Download Full-text

Patients with metastatic non-small cell lung cancer without molecular alterations or PD-L1 expression in Germany: Treatment and first outcome from the prospective German Registry Platform CRISP (AIO-TRK-0315)

Annals of Oncology ◽

10.1093/annonc/mdz260.022 ◽

2019 ◽

Vol 30 ◽

pp. v616

Author(s):

F. Griesinger ◽

W.E.E. Eberhardt ◽

H.-R. Bruch ◽

J. Rauh ◽

E. von der Heyde ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Molecular Alterations ◽

German Registry

Download Full-text

Abstract B179: Final results of a phase 1 study of cabozantinib (Cabo) in Japanese patients (pts) with expansion cohorts in non-small cell lung cancer (NSCLC) with defined molecular alterations

10.1158/1535-7163.targ-15-b179 ◽

2015 ◽

Author(s):

Hiroshi Nokihara ◽

Makoto Nishio ◽

Noboru Yamamoto ◽

Yutaka Fujiwawa ◽

Hidehito Horinouchi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase 1 ◽

Japanese Patients ◽

Small Cell Lung ◽

Phase 1 Study ◽

Molecular Alterations

Download Full-text

Reduced doses of dabrafenib and trametinib combination therapy for BRAF V600E-mutant non-small cell lung cancer prevent rhabdomyolysis and maintain tumor shrinkage: a case report

10.1186/s12885-020-6626-9 ◽

2020 ◽

Vol 20 (1) ◽

Author(s):

Yuta Adachi ◽

Naohiro Yanagimura ◽

Chiaki Suzuki ◽

Sakiko Ootani ◽

Azusa Tanimoto ◽

...

Keyword(s):

Lung Cancer ◽

Case Report ◽

Combination Therapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Tumor Shrinkage ◽

Small Cell Lung

Download Full-text

Dabrafenib Plus Trametinib for BRAF V600E-Mutant Non-small Cell Lung Cancer: A Patient Case Report

Clinical Drug Investigation ◽

10.1007/s40261-019-00823-3 ◽

2019 ◽

Vol 39 (10) ◽

pp. 1003-1007 ◽

Author(s):

Janet Pan

Keyword(s):

Lung Cancer ◽

Case Report ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Download Full-text

Interim results of a phase II study of the BRAF inhibitor (BRAFi) dabrafenib (D) in combination with the MEK inhibitor trametinib (T) in patients (pts) with BRAF V600E mutated (mut) metastatic non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.8006 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 8006-8006 ◽

Author(s):

David Planchard ◽

Harry J.M. Groen ◽

Tae Min Kim ◽

James R. Rigas ◽

Pierre Jean Souquet ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Braf Inhibitor ◽

Mek Inhibitor ◽

Small Cell Lung

Download Full-text

A Rare Case of Non-Small Cell Lung Cancer with BRAF V600E Gene: Case Report and Literature Review

Cureus ◽

10.7759/cureus.7055 ◽

2020 ◽

Author(s):

Dharti Patel ◽

Ateeq Mubarik ◽

Shilen Patel ◽

Ali Vaziri ◽

Salman Muddassir

Keyword(s):

Lung Cancer ◽

Case Report ◽

Literature Review ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Rare Case ◽

Small Cell Lung

Download Full-text

Dabrafenib and trametinib therapy in an elderly patient with non‐small cell lung cancer harboring the BRAF V600E mutation

Thoracic Cancer ◽

10.1111/1759-7714.13756 ◽

2020 ◽

Author(s):

Yosuke Dotsu ◽

Minoru Fukuda ◽

Noritaka Honda ◽

Hiroshi Gyotoku ◽

Yoshihisa Kohno ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patient ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Braf V600e Mutation ◽

Small Cell Lung

Download Full-text